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iMore Positive Fluid Balance
Could Explain Lower Risk of
Contrast Nephropathy
The paper by Marenzi et al. (1) in JACC: Cardiovascular Interven-
tions on prevention of contrast-induced nephropathy (CIN) using
furosemide with matched hydration deals with a pertinent and
pervasive problem. In this randomized trial of 170 patients who
received contrast media during coronary procedures, the investi-
gators compared standard-of-care hydration using intravenous
(IV) isotonic saline with furosemide-forced diuresis and IV iso-
tonic saline infusion matched to the urine output. This interven-
tion arm was associated with a lower incidence of CIN (4.6% vs.
18% in control subjects, p  0.005). However, a crucial piece of
data missing in the study, which might confound the results, is the
patients’ net fluid balance at the end of their respective protocols.
Adequate hydration before contrast administration is considered
the cornerstone of CIN prevention, although no randomized
controlled trial has studied the benefit of hydration alone. It would
have added to the validity of the study had the patients’ weights
been mentioned before and after the protocol because that could be
a good surrogate of the patients’ net hydration status. Estimation
of the net fluid balance based just on the difference between the
cumulative IV hydration and the urine outputs shows that patients
in the furosemide-matched hydration group were perhaps much
better volume repleted than the control subjects were. Patients in
the intervention arm received cumulative IV saline volume of
3,995  1,401 ml, with infusion rates matched to the urine output
(minus the initial 250-ml IV saline bolus). This indicates an even-
to-slightly-positive net fluid balance over the duration of the
protocol. The control group, however, received a cumulative IV
saline volume of 1,742  290 ml while putting out a urine volume
of 3,117  876 ml. This clearly suggests a net negative fluid
balance of about 1.3 l. Hence, how much of the final efficacy of
furosemide-matched hydration protocol over standard saline hy-
dration in preventing CIN could be attributed to the use of
furosemide, versus to the fact that patients in the intervention arm
just happened to be much better hydrated, remains debatable.
Some of the classic studies that studied volume repletion as a
measure to prevent CIN have shown that patients who did better
tended to be in an even-to-positive fluid balance, although the
results were not always statistically significant (2,3)
The study, however, definitely forces us to question our pur-
orted definition of “adequate” isotonic saline hydration in prep-
ration for contrast administration (1.0 to 1.5 ml/kg/h for 3 to 12 h
efore the procedure and continuing for 6 to 24 h after the
rocedure, per current guidelines) (4). The control group clearly
eceived hydration that was commensurate with guidelines, yet did
ignificantly worse than the intervention “superhydrated” arm.
his could be a novel proof of concept, worth validating by futurerials, wherein an isotonic saline hydration rate of as much as 600 tml/h for a shorter duration of about 6 h (as was used in the study)
might be a better prophylactic regimen against CIN compared
with what current guidelines recommend. A shorter hydration
regimen might also be logistically easier to implement and have
implications for cost savings.
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Hydration Is Critical for Prevention
of Contrast-Induced Nephropathy
Marenzi et al. (1) recently reported the results on a single-center,
prospective, randomized, nonblinded trial to investigate the role of
combined furosemide-induced high-volume diuresis and auto-
mated matched hydration (intervention group), combined with
standard saline hydration (control group), for the prevention of
contrast-induced nephropathy (CIN) in chronic kidney disease
patients undergoing coronary procedures.
However, it is worth noting that the 2 study groups were
different with respect to the fluids infused. In the intervention
group during the 6  1 h of treatment, the volume of saline
ydration was 3,995 1,401 ml. Urine output was matched to the
nfusion rate (minus the 250-ml fluid bolus received as specified in
he protocol). The intervention group thus had a net positive fluid
